Covid-19: WHO's Solidarity clinical trial enters a new phase with three new candidate dru

The World Health Organisation (WHO) has announced the next phase in its Solidarity trial: Solidarity PLUS will enroll hospitalised Covid-19 patients to test three new drugs. These therapies – artesunate, imatinib and infliximab – were selected by an ...

from Google Alert - Business https://ift.tt/3jNDb1v
The World Health Organisation (WHO) has announced the next phase in its Solidarity trial: Solidarity PLUS will enroll hospitalised Covid-19 patients to test three new drugs. These therapies – artesunate, imatinib and infliximab – were selected by an ... https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize